Lenz HJ - Search Results

1

B cell and B cell-related pathways for novel cancer treatments.

Tokunaga R, Naseem M, Lo JH, Battaglin F, Soni S, Puccini A, Berger MD, Zhang W, Baba H, Lenz HJ. Tokunaga R, et al. Among authors: lenz hj. Cancer Treat Rev. 2019 Feb;73:10-19. doi: 10.1016/j.ctrv.2018.12.001. Epub 2018 Dec 3. Cancer Treat Rev. 2019. PMID: 30551036 Free PMC article. Review.

2

The -9Ala/-9Val polymorphism in the mitochondrial targeting sequence of the manganese superoxide dismutase gene (MnSOD) is associated with age among Hispanics with colorectal carcinoma.

Stoehlmacher J, Ingles SA, Park DJ, Zhang W, Lenz HJ. Stoehlmacher J, et al. Among authors: lenz hj. Oncol Rep. 2002 Mar-Apr;9(2):235-8. Oncol Rep. 2002. PMID: 11836586

3

Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer.

Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei D, Groshen S, Lenz HJ. Park DJ, et al. Among authors: lenz hj. Int J Colorectal Dis. 2002 Jan;17(1):46-9. doi: 10.1007/s003840100358. Int J Colorectal Dis. 2002. PMID: 12018454

4

Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer.

Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC, Lenz HJ. Stoehlmacher J, et al. Among authors: lenz hj. J Natl Cancer Inst. 2002 Jun 19;94(12):936-42. doi: 10.1093/jnci/94.12.936. J Natl Cancer Inst. 2002. PMID: 12072547

5

Clinical update: proteasome inhibitors in solid tumors.

Lenz HJ. Lenz HJ. Cancer Treat Rev. 2003 May;29 Suppl 1:41-8. doi: 10.1016/s0305-7372(03)00082-3. Cancer Treat Rev. 2003. PMID: 12738242 Review.

6

Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.

Zhang W, Park DJ, Lu B, Yang DY, Gordon M, Groshen S, Yun J, Press OA, Vallböhmer D, Rhodes K, Lenz HJ. Zhang W, et al. Among authors: lenz hj. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):600-5. Clin Cancer Res. 2005. PMID: 15701846

7

Molecular determinants of cetuximab efficacy.

Vallböhmer D, Zhang W, Gordon M, Yang DY, Yun J, Press OA, Rhodes KE, Sherrod AE, Iqbal S, Danenberg KD, Groshen S, Lenz HJ. Vallböhmer D, et al. Among authors: lenz hj. J Clin Oncol. 2005 May 20;23(15):3536-44. doi: 10.1200/JCO.2005.09.100. J Clin Oncol. 2005. PMID: 15908664

8

Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer.

Zhang W, Stoehlmacher J, Park DJ, Yang D, Borchard E, Gil J, Tsao-Wei DD, Yun J, Gordon M, Press OA, Rhodes K, Groshen S, Lenz HJ. Zhang W, et al. Among authors: lenz hj. Clin Colorectal Cancer. 2005 Jul;5(2):124-31. doi: 10.3816/ccc.2005.n.025. Clin Colorectal Cancer. 2005. PMID: 16098254

9

ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.

Park DJ, Zhang W, Stoehlmacher J, Tsao-Wei D, Groshen S, Gil J, Yun J, Sones E, Mallik N, Lenz HJ. Park DJ, et al. Among authors: lenz hj. Clin Adv Hematol Oncol. 2003 Mar;1(3):162-6. Clin Adv Hematol Oncol. 2003. PMID: 16224397

10

Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation.

Gordon MA, Gil J, Lu B, Zhang W, Yang D, Yun J, Schneider S, Groshen S, Iqbal S, Press OA, Rhodes K, Lenz HJ. Gordon MA, et al. Among authors: lenz hj. Pharmacogenomics. 2006 Jan;7(1):67-88. doi: 10.2217/14622416.7.1.67. Pharmacogenomics. 2006. PMID: 16354126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

681 results

Search Page